AbbVie to acquire Apogee Therapeutics in $10.9B deal
AbbVie announced Monday it will acquire Apogee Therapeutics, a biotechnology company with operations in Waltham, in a deal valued at about $10.9 billion. Neither company has stated whether Apogee will […]









